Terri Conneran, Dr. Jacob Kaufman

In this video about KRAS biomarker lung cancer you will learn the answers to these questions:

1. What is KRAS lung cancer?

2. I got diagnosed with KRAS lung cancer. What do I do now?

3. Should I see a KRAS specialist?

KRAS Biomarker and Lung Cancer

According to Dr. Jacob Kaufman, of The James Cancer Center at Ohio State University, KRAS mutations are among the most commonly mutated genes in lung cancer. #KRAS mutation lung cancer is present in approximately 15-25% of patients with non-small cell lung cancer (NSCLC). Many patients with #lungcancer, including many who test positive for the KRAS #biomarker, don’t have any signs or symptoms in the early stages. This is why many lung cancer patients are not diagnosed until the lung cancer is advanced.

What is the meaning of KRAS?

Is KRAS Biomarker Good or Bad? KRAS is neither good nor bad. It is simply a gene that makes a protein that is involved in cell signaling pathways that control cell growth, cell maturation, and cell death. KRAS stands for “Kirsten rat sarcoma viral oncogene homolog.”

In this KRAS Hope With Answers℠ video, Terri Conneran, a KRAS-positive lung cancer patient and advocate, asks Dr. Kaufman important questions about KRAS biomarker lung cancer. Dr. Kaufman’s explanations can help every newly diagnosed KRAS lung cancer patient.

KRAS Biomarker Hope With Answers℠ Videos

Available online, anytime you need it and anywhere you are, Hope With Answers℠ videos pair lung cancer patients with leading lung cancer doctors. The patients ask the questions that matter most to lung cancer patients. And, they get the answers from doctors who specialize in lung cancer. These lung cancer specialists dedicate their careers to staying up to date on the best tests, the latest effective treatment options, and what exciting things are on the horizon to help lung cancer patients.

The Hope With Answers℠ video series includes videos on biomarker testing, staging in lung cancer, targeted therapies, immunotherapies, thoracic surgery, KRAS biomarker, ALK biomarker, clinical trials, and more. The videos are designed as stepping stones. Intro videos discuss the most basic information. Intermediate videos offer more profound knowledge. And, In-Depth videos provide the most intricate details.